Anti-type I interferon antibodies as a cause of severe COVID-19

enthalten in: Faculty reviews | 2022

von Fajgenbaum, D. | Hayday, A. | Rogers, A. | +3

Comment on : HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease: reply

enthalten in: Rheumatology (Oxford, England) | 2021

von Kawano, M. | Sato, Y. | Fajgenbaum, D.

Commentary on A Case of Rapid Deterioration with Marked Hypergammaglobulinemia

enthalten in: Clinical chemistry | 2020

von Fajgenbaum, D. | Phillips, A.

The collaborative network approach : a new framework to accelerate Castleman's disease and other rare disease research

enthalten in: The Lancet. Haematology | 2016

von Fajgenbaum, D. | Ruth, J. | Kelleher, D. | +1